血液培養検査市場：製品別、タイプ別、技術別、培養タイプ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

世界の血液培養検査の市場規模は、予測期間の2024年～2031年に9.05％のCAGRで拡大し、2023年の53億2,000万米ドルから2031年には106億4,000万米ドルに成長すると予測されています。血液培養検査市場は、感染症や敗血症の罹患率の上昇、早期診断と治療に重点を置いた政府の取り組みと資金の増加により、予測期間中に大きく成長し、勢いを増すと予測されます。

血液培養検査は、血液サンプル中の細菌またはその他の微生物を検出するための診断プロセスです。この検査は、医療専門家が血液中に存在する正確な感染症を特定し、適切な治療方針を指示するのに役立ちます。感染症の有病率の増加、診断技術の進歩、患者ケアを改善するための早期かつ正確な診断への注目の高まりはすべて、血液培養検査の需要増加の一因となっています。さらに、血液培養システムの進歩やヘルスケア投資の増加が業界を前進させています。新製品の発売により、血液検査市場は活況を呈しています。例えば、試験管サービスの世界的リーダーであるbioMerieuxは、2024年6月にVITEK REVEAL ASTシステムの米国FDA承認を取得しました。

抗菌薬耐性（AMR）の蔓延は、優れた診断ソリューションの必要性を強調することで、血液培養検査市場を強力にサポートしています。抗菌薬耐性は血流感染症の治療をより困難にし、病原体とその耐性パターンの正確な検出に対する需要の高まりを生み出しています。世界保健機関（WHO）によると、抗菌薬耐性（AMR）は世界の健康脅威のトップに分類され、2019年には約495万人が抗菌薬耐性が原因で死亡するとされています。対策を講じなければ、AMRはさらに重大な問題に発展する可能性があります。世界銀行は、2050年までにAMRが世界のヘルスケアコストをさらに1兆米ドル増加させると見積もっています。これらのコストは、患者数の増加、感染症の治療の困難化、入院期間の長期化と高額化、高額な治療費などから生じる。この課題は、研究開発への投資を加速させることで即座に対応され、迅速な結果と詳細な耐性データをもたらす高度な血液培養検査に結実し、抗菌薬耐性の適切な管理と患者の転帰の改善を可能にしています。

当レポートでは、世界の血液培養検査市場について調査し、市場の概要とともに、製品別、タイプ別、技術別、培養タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の血液培養検査市場の見通し、2017年～2031年

• 市場規模の分析と予測
• 市場シェア分析と予測
• 市場マップ分析、2023年
  • 製品別
  • タイプ別
  • 技術別
  • 培養タイプ別
  • エンドユーザー別
  • 地域別

第5章 北米の血液培養検査市場の見通し、2017年～2031年

第6章 欧州の血液培養検査市場の見通し、2017年～2031年

第7章 アジア太平洋の血液培養検査市場の見通し、2017年～2031年

第8章 南米の血液培養検査市場の見通し、2017年～2031年

第9章 中東・アフリカの血液培養検査市場の見通し、2017年～2031年

第10章 需要供給分析

第11章 輸出入の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

第17章 市場の動向と発展

第18章 規制枠組みとイノベーション

第19章 特許の情勢

第20章 ケーススタディ

第21章 競合情勢

• 市場リーダートップ5の競合マトリックス
• 参入企業トップ5のSWOT分析
• 市場の主要参入企業トップ10の情勢
  • bioMerieux
  • Bruker Corporation
  • Becton, Dickinson and Company
  • T2 Biosystems Inc.
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Siemens Healthineers
  • DiaSorin S.p.A.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories

第22章 戦略的提言

第23章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 3. Global Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 4. Global Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 5. Global Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 6. Global Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 7. Global Blood Culture Tests Market Share (%), By Region, 2017-2031F
• Figure 8. North America Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 9. North America Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 10. North America Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 11. North America Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 12. North America Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 13. North America Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 14. North America Blood Culture Tests Market Share (%), By Country, 2017-2031F
• Figure 15. United States Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 16. United States Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 17. United States Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 18. United States Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 19. United States Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 20. United States Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 21. Canada Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 22. Canada Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 23. Canada Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 24. Canada Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 25. Canada Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 26. Canada Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 27. Mexico Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 28. Mexico Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 29. Mexico Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 30. Mexico Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 31. Mexico Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 32. Mexico Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 34. Europe Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 35. Europe Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 36. Europe Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 37. Europe Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 38. Europe Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 39. Europe Blood Culture Tests Market Share (%), By Country, 2017-2031F
• Figure 40. Germany Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 41. Germany Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 42. Germany Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 43. Germany Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 44. Germany Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 45. Germany Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 46. France Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 47. France Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 48. France Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 49. France Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 50. France Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 51. France Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 52. Italy Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 53. Italy Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 54. Italy Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 55. Italy Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 56. Italy Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 57. Italy Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 58. United Kingdom Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 59. United Kingdom Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 60. United Kingdom Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 61. United Kingdom Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 62. United Kingdom Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 63. United Kingdom Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 64. Russia Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 65. Russia Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 66. Russia Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 67. Russia Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 68. Russia Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 69. Russia Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 70. Netherlands Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 71. Netherlands Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 72. Netherlands Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 73. Netherlands Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 74. Netherlands Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 75. Netherlands Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 76. Spain Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 77. Spain Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 78. Spain Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 79. Spain Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 80. Spain Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 81. Spain Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 82. Turkey Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 83. Turkey Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 84. Turkey Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 85. Turkey Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 86. Turkey Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 87. Turkey Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 88. Poland Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 89. Poland Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 90. Poland Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 91. Poland Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 92. Poland Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 93. Poland Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 94. South America Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 95. South America Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 96. South America Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 97. South America Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 98. South America Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 99. South America Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 100. South America Blood Culture Tests Market Share (%), By Country, 2017-2031F
• Figure 101. Brazil Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 102. Brazil Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 103. Brazil Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 104. Brazil Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 105. Brazil Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 106. Brazil Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 107. Argentina Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 108. Argentina Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 109. Argentina Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 110. Argentina Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 111. Argentina Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 112. Argentina Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 113. Asia-Pacific Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 114. Asia-Pacific Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 115. Asia-Pacific Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 116. Asia-Pacific Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 117. Asia-Pacific Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 118. Asia-Pacific Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 119. Asia-Pacific Blood Culture Tests Market Share (%), By Country, 2017-2031F
• Figure 120. India Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 121. India Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 122. India Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 123. India Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 124. India Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 125. India Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 126. China Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 127. China Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 128. China Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 129. China Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 130. China Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 131. China Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 132. Japan Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 133. Japan Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 134. Japan Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 135. Japan Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 136. Japan Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 137. Japan Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 138. Australia Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 139. Australia Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 140. Australia Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 141. Australia Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 142. Australia Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 143. Australia Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 144. Vietnam Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 145. Vietnam Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 146. Vietnam Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 147. Vietnam Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 148. Vietnam Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 149. Vietnam Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 150. South Korea Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 151. South Korea Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 152. South Korea Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 153. South Korea Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 154. South Korea Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 155. South Korea Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 156. Indonesia Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 157. Indonesia Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 158. Indonesia Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 159. Indonesia Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 160. Indonesia Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 161. Indonesia Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 162. Philippines Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 163. Philippines Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 164. Philippines Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 165. Philippines Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 166. Philippines Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 167. Philippines Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 168. Middle East & Africa Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 169. Middle East & Africa Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 170. Middle East & Africa Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 171. Middle East & Africa Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 172. Middle East & Africa Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 173. Middle East & Africa Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 174. Middle East & Africa Blood Culture Tests Market Share (%), By Country, 2017-2031F
• Figure 175. Saudi Arabia Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 176. Saudi Arabia Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 177. Saudi Arabia Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 178. Saudi Arabia Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 179. Saudi Arabia Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 180. Saudi Arabia Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 181. UAE Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 182. UAE Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 183. UAE Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 184. UAE Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 185. UAE Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 186. UAE Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 187. South Africa Blood Culture Tests Market, By Value, In USD Billion, 2017-2031F
• Figure 188. South Africa Blood Culture Tests Market Share (%), By Product, 2017-2031F
• Figure 189. South Africa Blood Culture Tests Market Share (%), By Type, 2017-2031F
• Figure 190. South Africa Blood Culture Tests Market Share (%), By Technology, 2017-2031F
• Figure 191. South Africa Blood Culture Tests Market Share (%), By Culture Type, 2017-2031F
• Figure 192. South Africa Blood Culture Tests Market Share (%), By End-user, 2017-2031F
• Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 194. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 195. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 196. By Culture Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 197. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global blood culture tests market is projected to witness a CAGR of 9.05% during the forecast period 2024-2031, growing from USD 5.32 billion in 2023 to USD 10.64 billion in 2031. The blood culture tests market is anticipated to grow significantly and gain momentum over the course of the forecast period owing to the rising incidence of infectious diseases and sepsis cases, increased government initiatives and funding coupled with a strong emphasis on early diagnosis and treatment.

A blood culture test is a diagnostic process for detecting bacteria or other microorganisms in a blood sample. This test helps medical professionals identify the precise infection present in the blood and directs the course of appropriate treatment. The increasing prevalence of infectious diseases, advancements in diagnostic technology, and a growing focus on early and accurate diagnosis to improve patient care are all contributing factors to the growth in demand for blood culture tests. Furthermore, advances in blood culture systems and higher healthcare investments are propelling the industry forward. The new product launches keep this blood tests market active; for instance, in June 2024, bioMerieux, a world leader in providing in vitro services, received US-FDA approval for its VITEK REVEAL AST System.

Rising Antimicrobial Resistance Burden in Bloodstream Infections

The growing prevalence of Antimicrobial Resistance (AMR) strongly supports the blood culture tests market by highlighting the need for superior diagnostic solutions. Antimicrobial resistance makes the treatment of bloodstream infection more challenging and creates a growing demand for accurate detection of pathogens and their resistance patterns. According to the World Health Organization (WHO), Antimicrobial Resistance (AMR) is classified as a top global health threat, with approximately 4.95 million deaths attributed to it in 2019. If not addressed, AMR could escalate into a more significant issue. The World Bank estimates that by 2050, AMR could increase global healthcare costs by an additional USD 1 trillion. These costs arise from the increased numbers of cases, enhanced difficulty of treating infections, longer and more expensive hospitalization, and costly treatments. This challenge has been immediately responded to through accelerated investment in research and development, culminating in advanced blood culture tests that bring fast results and detailed resistance data, enabling good management of antimicrobial resistance and improving patient outcomes.

Increasing Awareness and Fundings Towards Bloodstream Infections

The enhanced awareness and favorable funding scenario to cater to bloodstream infections will further fuel the blood culture tests market concerning higher innovation and access to advanced diagnostics. With increased recognition of the serious consequences of such infections, the industry has experienced significant growth in government and private sector funding. For instance, in August 2024, the Government of Australia invested over USD 3.7 million for enhanced infection control research in geriatric care facilities. Similarly, in February 2024, Wellcome Trust, a London-based health research foundation, funded USD 5.46 million (£4.2 million) to a collaborative team of researchers from Ireland and the United Kingdom to study major causes of fatal bloodstream infections. Such investments are pushing the development of integrated diagnostic platforms to improve testing efficiency and accuracy. This growing attention toward the problem of bloodstream infection, along with the financial backing needed, is therefore playing a growth-promotional role in the blood culture tests market, hence representing one of the major areas of development in healthcare.

Dominance of Consumables in the Blood Culture Tests Market

The consumables segment is expected to dominate the blood culture tests market because it comprises a wide range of products used in blood culture testing. This includes vials, culture media, test kits, assays and reagents. As the accuracy and effectiveness of blood culture testing depend greatly on the quality of the culture media, companies are now highly focused on enhancing its quality. Apart from this, companies producing new assays, culture media, and test kits are currently in the pipeline for FDA clearance. Therefore, this shows that the demand for sophisticated and high-end consumables is increasing. The innovation trend materializing into regulatory approval proves an increasing need for reliable and effective products in blood culture testing. For instance, in June 2024, Diasorin S.p.A. received US FDA (510K) approval for its LIAISON PLEX Yeast blood culture assay, which has enhanced their diagnostic capabilities for bloodstream infections by detecting 16 different fungal infections. Likewise, in April 2024, Accelerate Diagnostics, Inc. received the US FDA (510k) clearance for its innovative automated positive blood culture sample preparation platform, the Accelerate ArcSystem and BC Kit.

North America Dominates Blood Culture Tests Market

North America dominates the blood culture tests market due to the high incidence of bloodstream infections in the United States and Canada, which necessitate these tests. Many aspects contribute to this dominance, including government initiatives aimed at preventing and controlling septicemia, increased investments in R&D, and being home to major players in the blood culture tests market. Some companies are merging their activities with others to improve their diagnostic products leading to better diagnostic results. For example, in November 2023, Accelerate Diagnostics, Inc. collaborated with Bruker Corporation, the manufacturer of the MALDI Biotyper system for microbial identification. This agreement enabled the integration of the Arc system from Accelerate Diagnostics with Bruker MALDI Biotyper Sirius instruments and Sepsityper software to empower laboratories to fight sepsis with better technology. Moreover, in October 2022, Becton, Dickinson and Company, one of the biggest medical technology companies in the world, entered a partnership with Magnolia Medical Technologies, Inc. This will help reduce blood culture contamination in hospitals across the United States to enable better test accuracy and clinical outcomes.

Future Market Scenario (2024-2031F)

Government and regulatory agencies are working with companies to enhance practices that consider supply challenges for blood culture testing. For example, the US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) are currently working with BD Life Sciences to understand better the supply issues and be sure that users have information about best practices in using blood cultures and quality assurance. Indeed, these efforts demonstrate the continuing commitment to improve blood culture testing and practice in the future.

Researchers are working on reducing the overall time taken to diagnose critical health issues such as bloodstream infections and sepsis. For this, they are using advanced techniques combined with traditional blood culture testing to reduce the turnaround time. For instance, a publication in 2024 made suggestions to reduce the time between sample collection and treatment decisions for sepsis to seven to nine hours using nanopore sequencing. These developments show blood culture testing holds a promising future for accurate diagnosis and, hence, can lead to faster and more effective treatments.

Key Players Landscape and Outlook

Bruker Corporation, bioMerieux, Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., and Abbott Laboratories are among the blood culture tests market's leading players. The blood culture tests market is very competitive, with various competitors operating in the country and regional markets. With cutting-edge technologies as well as rapid testing methods, these companies are leading in the blood culture tests market with the goal of increasing diagnostic accuracy as well as speed. Their continued investments in research and development, as well as strategic collaborations, are critical to meeting the changing needs of the healthcare sector and improving patient outcomes. For instance,

In January 2024, bioMerieux, a leading global in vitro diagnostics company, completed the acquisition of LUMED, a Canadian software startup. LUMED specializes in clinical decision support systems that help hospitals with antimicrobial prescription and infection surveillance. The deal is valued at around USD 9.9 million (9 million euros). This acquisition will expand the data analytics portfolio of BioMerieux, with a focus on infection prevention and control.

In March 2023, Biofire Defense LLC, a bioMerieux affiliate known for its innovative pathogen detection technologies, partnered with the Biomedical Advanced Research and Development Authority (BARDA). BARDA is a part of the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response, and it collaborates with Biofire to accelerate the development of the SPECIFIC REVEAL Rapid AST System. This novel, modular antimicrobial susceptibility testing technology intends to offer results within five hours after detecting a positive blood culture, thereby increasing the speed and efficiency of infection diagnosis.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Blood Culture Tests Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Instruments
      • 4.2.1.1.1. Automated Blood Culture System
      • 4.2.1.1.2. Supporting Laboratory Equipment
      • 4.2.1.1.3. Software and Services
    • 4.2.1.2. Consumables
      • 4.2.1.2.1. Blood Culture Media
      • 4.2.1.2.2. Assay Kits and Reagents
      • 4.2.1.2.3. Blood Culture Accessories
      • 4.2.1.2.4. Others
  • 4.2.2. By Type
    • 4.2.2.1. Manual Blood Culture Testing
    • 4.2.2.2. Automated Blood Culture Testing
  • 4.2.3. By Technology
    • 4.2.3.1. Culture-Based
    • 4.2.3.2. Proteomic Technology
    • 4.2.3.3. Molecular Technology
      • 4.2.3.3.1. Microarrays
      • 4.2.3.3.2. Polymerase Chain Reaction (PCR)
      • 4.2.3.3.3. Peptide Nucleic Acid-Fluorescent In-situ Hybridization (PNA-FiSH)
  • 4.2.4. By Culture Type
    • 4.2.4.1. Bacterial
    • 4.2.4.2. Fungal
    • 4.2.4.3. Micro-bacterial
  • 4.2.5. By End-user
    • 4.2.5.1. Hospital Laboratories
    • 4.2.5.2. Diagnostic Laboratories
    • 4.2.5.3. Others
  • 4.2.6. By Region
    • 4.2.6.1. North America
    • 4.2.6.2. Europe
    • 4.2.6.3. Asia-Pacific
    • 4.2.6.4. South America
    • 4.2.6.5. Middle East and Africa
  • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product
  • 4.3.2. By Type
  • 4.3.3. By Technology
  • 4.3.4. By Culture Type
  • 4.3.5. By End-user
  • 4.3.6. By Region

5. North America Blood Culture Tests Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Instruments
      • 5.2.1.1.1. Automated Blood Culture System
      • 5.2.1.1.2. Supporting Laboratory Equipment
      • 5.2.1.1.3. Software and Services
    • 5.2.1.2. Consumables
      • 5.2.1.2.1. Blood Culture Media
      • 5.2.1.2.2. Assay Kits and Reagents
      • 5.2.1.2.3. Blood Culture Accessories
      • 5.2.1.2.4. Others
  • 5.2.2. By Type
    • 5.2.2.1. Manual Blood Culture Testing
    • 5.2.2.2. Automated Blood Culture Testing
  • 5.2.3. By Technology
    • 5.2.3.1. Culture-Based
    • 5.2.3.2. Proteomic Technology
    • 5.2.3.3. Molecular Technology
      • 5.2.3.3.1. Microarrays
      • 5.2.3.3.2. Polymerase Chain Reaction (PCR)
      • 5.2.3.3.3. Peptide Nucleic Acid-Fluorescent In-situ Hybridization (PNA-FiSH)
  • 5.2.4. By Culture Type
    • 5.2.4.1. Bacterial
    • 5.2.4.2. Fungal
    • 5.2.4.3. Micro-bacterial
  • 5.2.5. By End-user
    • 5.2.5.1. Hospital Laboratories
    • 5.2.5.2. Diagnostic Laboratories
    • 5.2.5.3. Others
  • 5.2.6. By Country Share
    • 5.2.6.1. United States
    • 5.2.6.2. Canada
    • 5.2.6.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Blood Culture Tests Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product
        • 5.3.1.2.1.1. Instruments
        • 5.3.1.2.1.1.1. Automated Blood Culture System
        • 5.3.1.2.1.1.2. Supporting Laboratory Equipment
        • 5.3.1.2.1.1.3. Software and Services
        • 5.3.1.2.1.2. Consumables
        • 5.3.1.2.1.2.1. Blood Culture Media
        • 5.3.1.2.1.2.2. Assay Kits and Reagents
        • 5.3.1.2.1.2.3. Blood Culture Accessories
        • 5.3.1.2.1.2.4. Others
      • 5.3.1.2.2. By Type
        • 5.3.1.2.2.1. Manual Blood Culture Testing
        • 5.3.1.2.2.2. Automated Blood Culture Testing
      • 5.3.1.2.3. By Technology
        • 5.3.1.2.3.1. Culture-Based
        • 5.3.1.2.3.2. Proteomic Technology
        • 5.3.1.2.3.3. Molecular Technology
        • 5.3.1.2.3.3.1. Microarrays
        • 5.3.1.2.3.3.2. Polymerase Chain Reaction (PCR)
        • 5.3.1.2.3.3.3. Peptide Nucleic Acid-Fluorescent In-situ Hybridization (PNA-FiSH)
      • 5.3.1.2.4. By Culture Type
        • 5.3.1.2.4.1. Bacterial
        • 5.3.1.2.4.2. Fungal
        • 5.3.1.2.4.3. Micro-bacterial
      • 5.3.1.2.5. By End-user
        • 5.3.1.2.5.1. Hospital Laboratories
        • 5.3.1.2.5.2. Diagnostic Laboratories
        • 5.3.1.2.5.3. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Blood Culture Tests Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Blood Culture Tests Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Blood Culture Tests Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Blood Culture Tests Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

• 18.1. Clinical Trials
• 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

• 21.1. Competition Matrix of Top 5 Market Leaders
• 21.2. SWOT Analysis for Top 5 Players
• 21.3. Key Players Landscape for Top 10 Market Players
  • 21.3.1. bioMerieux
    • 21.3.1.1. Company Details
    • 21.3.1.2. Key Management Personnel
    • 21.3.1.3. Products and Services
    • 21.3.1.4. Financials (As Reported)
    • 21.3.1.5. Key Market Focus and Geographical Presence
    • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 21.3.2. Bruker Corporation
  • 21.3.3. Becton, Dickinson and Company
  • 21.3.4. T2 Biosystems Inc.
  • 21.3.5. F. Hoffmann-La Roche AG
  • 21.3.6. Danaher Corporation
  • 21.3.7. Siemens Healthineers
  • 21.3.8. DiaSorin S.p.A.
  • 21.3.9. Thermo Fisher Scientific Inc.
  • 21.3.10. Abbott Laboratories

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer